---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-023626"
form_type: "8-K/A"
ticker: "PPCB"
cik: "0001517681"
company_name: "Propanc Biopharma, Inc."
filed_at: "2024-06-13T23:59:59+00:00"
generated_at: "2026-06-01T04:36:00.403279+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Propanc Biopharma enters two loan agreements totaling AUD $120,000 at 12% interest

## Summary
- First loan of AUD $20,000 on June 3, 2024; 12% annual interest; matures June 3, 2025.
- Second loan of AUD $100,000 on June 5, 2024; 12% annual interest; matures June 5, 2025.
- Both loans for general working capital; company may prepay without penalty.
- Loans issued as unregistered securities under Section 4(a)(2) and Rule 506.

## SEC filing metadata
- accession: 0001493152-24-023626
- form_type: 8-K/A
- ticker: PPCB
- cik: 0001517681
- company_name: Propanc Biopharma, Inc.
- filed_at: 2024-06-13T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517681/000149315224023626/0001493152-24-023626-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517681/000149315224023626/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-023626
- JSON: https://secwatch.observer/filing/0001493152-24-023626.json
- Plain text: https://secwatch.observer/filing/0001493152-24-023626.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.